viral
infect
threaten
cell
one
first
measur
take
induc
apoptosi
restrict
viral
replic
die
way
host
cell
like
gener
specif
signal
aim
trigger
immun
system
innat
andor
adapt
respons
allow
erad
hand
virus
evolv
huge
arsen
strategi
meant
either
counteract
deal
destruct
process
ensur
apoptot
cell
death
accompani
characterist
morpholog
chang
cellular
roundingup
volum
reduct
chromatin
condens
nuclear
fragment
plasma
membran
molecular
level
activ
first
initi
effector
cysteinyl
aspart
proteinas
activ
caspas
act
catalyt
cy
hydrolyz
peptid
bond
within
substrat
stringent
specif
asp
residu
posit
natur
residu
posit
depend
caspas
caspas
substrat
includ
larg
number
varieti
cellular
protein
particip
cleavag
strong
apoptosisrel
morpholog
chang
well
physiolog
process
interestingli
viral
protein
also
like
cleav
caspas
four
report
suggest
advantag
associ
virus
sinc
number
greatli
increas
least
virus
known
express
protein
undergo
caspas
cleavag
aim
updat
cleavag
discuss
biolog
relev
apoptosi
inhibit
improv
attenu
viral
amplif
caspas
cleavag
vp
highlight
potenti
new
fascin
viral
strategi
handl
apoptosi
induct
apoptosi
induct
infect
cell
meant
jeopard
viral
replic
therefor
mani
virus
develop
strategi
inhibit
process
variou
mechan
among
inhibit
caspas
activ
cleavag
viral
protein
constitut
effect
way
achiev
apoptosi
suppress
tabl
baculovirus
invertebr
virus
encod
sever
antiapoptot
product
includ
iap
lack
baculoviru
prototyp
autographa
californica
multicapsid
nucleopolyhedroviru
acmnpv
induc
apoptosi
fail
replic
wherea
rescu
inhibit
cell
death
restor
viral
interestingli
proteolyt
cleav
cleavag
site
requir
apoptosi
suppress
directli
inhibit
mani
caspas
includ
insect
sfcaspas
human
caspas
mous
caspas
inde
cleavag
product
remain
irrevers
associ
caspas
coval
thioester
bond
residu
caspas
catalyt
although
relat
yet
exhibit
differ
caspas
cleavag
site
confer
antiapoptot
caspas
suppress
also
involv
cleavag
stabl
associ
target
caspas
although
act
besid
effector
caspas
also
affect
initi
caspas
fail
suppress
like
insect
sfcaspas
x
human
initi
caspas
rather
similarli
product
gene
express
crustaceaninfect
white
spot
syndrom
viru
wssv
also
shown
exert
antiapoptot
properti
insect
cell
stabli
express
gene
strongli
resist
viral
actinomycin
dinduc
like
also
refer
suggest
act
inhibitor
abl
block
sever
caspas
includ
human
caspas
well
insect
sfcaspas
vitro
abil
suppress
caspas
activ
associ
consensu
caspas
cleavag
site
target
caspas
requir
caspas
inhibit
although
site
specif
target
one
proteas
three
need
reach
maxim
caspas
baculovirus
wssv
inhibit
apoptosi
crucial
achiev
life
cycl
differ
invertebrateinfect
virus
encod
protein
exhibit
activ
caspas
cleavag
site
cellular
substrat
special
abil
irrevers
freez
proteas
activ
lead
potent
broad
caspas
inhibit
keep
host
cell
machineri
avail
fit
viral
amplif
unlik
express
antiapoptot
product
requir
apoptosi
virus
surviv
way
counterintuit
strategi
yet
evolv
sever
virus
involv
caspas
cleavag
tabl
parvoviru
aleutian
mink
diseas
viru
amdv
lead
singl
cell
level
either
permiss
infect
name
high
level
viral
dna
replic
product
virus
persist
infect
low
viral
dna
replic
almost
product
progeni
virion
permiss
infect
amdv
induc
caspas
activ
necessari
viral
requir
associ
protein
cleav
two
caspas
site
lead
five
one
site
mutat
within
amdv
molecular
clone
viral
product
strongli
reduc
even
abort
site
disrupt
interestingli
wildtyp
wt
protein
exert
replic
transcript
function
mostli
nuclear
one
cleavag
site
disrupt
protein
remain
cytosol
result
dramat
decreas
viral
protein
vp
express
ctermin
product
also
nuclear
suggest
activ
involv
transport
wt
therefor
apoptosi
induct
full
replic
occur
lead
permiss
infect
convers
without
caspas
activ
amdv
amplif
would
limit
might
allow
lytic
viru
establish
persist
infect
human
papillomaviru
hpv
mostli
known
infect
epitheli
cell
genit
tract
caus
cervic
cancer
epitheli
differenti
hpv
induc
dna
damag
respons
lead
caspas
interestingli
hpv
protein
involv
viral
dna
replic
target
caspas
site
conserv
genit
hpv
prevent
cleavag
reduc
viral
amplif
compar
chemic
induc
apoptosi
hpvinduc
apoptot
marker
limit
interestingli
hpv
increas
level
antiapoptot
survivin
hpv
pro
antiapoptot
properti
might
achiev
caspas
activ
threshold
suffici
cleavag
viral
amplif
lethal
host
cell
besid
hpv
protein
cleav
caspas
well
function
consequ
remain
human
astrovirus
hastv
respons
gastroenter
strain
encod
precursor
viral
capsid
protein
whose
process
yield
besid
hastv
activ
caspas
vitro
caspas
abl
target
caspas
silenc
reduc
gener
infect
interestingli
intracellular
process
progeni
virion
releas
lost
presenc
pan
caspas
inhibitor
howev
opposit
first
suggest
viral
releas
need
caspas
activ
need
process
yield
fulli
infecti
virus
requir
shorter
polypeptid
creat
process
trypsin
thu
first
cleav
gener
like
repres
crucial
intermedi
event
hastv
infect
sarscoronaviru
sarscov
fairli
new
rna
viru
respons
sever
acut
respiratori
diseas
sarscov
lead
either
permiss
persist
infect
strong
cytopath
effect
high
viral
titer
opposit
respect
interestingli
nucleocapsid
protein
n
structur
nonstructur
function
proteolyt
process
cell
undergo
lytic
cycl
ectop
express
use
pharmalog
approach
n
protein
demonstr
target
caspas
permiss
infect
n
protein
local
cytosol
nucleu
remain
cytosol
cell
undergo
persist
infect
moreov
prevent
n
transloc
nucleu
mutat
nuclear
local
signal
abolish
cleavag
caspas
thu
permiss
infect
associ
n
transloc
nucleu
possibl
ensu
caspas
cleavag
nevertheless
mechan
underli
viral
replic
n
subcellular
local
n
caspas
process
unknown
far
sharp
contrast
baculovirus
wssv
sever
differ
virus
evolv
hijack
apoptosi
caspas
cleavag
requir
reach
optim
viral
amplif
base
welldescrib
case
amdv
hypothes
caspaserel
product
creat
cleavag
display
novel
properti
requir
achiev
viral
life
cycl
case
apoptosi
induct
host
cell
lead
exactli
expect
name
viral
attenu
surprisingli
help
viral
protein
cleavag
possibl
viral
advantag
result
event
discuss
tabl
kaposi
sarcomaassoci
herpesviru
kshv
establish
longterm
infect
lead
kaposi
sarcoma
go
either
latent
lytic
cycl
kshv
reactiv
mta
kssm
detect
western
blot
smaller
product
abolish
pan
caspas
inhibitor
vitro
caspas
activ
kshv
reactiv
lesser
extent
caspas
abl
process
interestingli
coexpress
assay
show
cleavag
product
ie
lack
residu
longer
abl
promot
viral
lytic
gene
express
accordingli
complement
stabl
cell
line
contain
kshv
genom
ectop
wt
uncleav
promot
lytic
gene
express
lack
residu
consist
number
cellfre
viru
particl
dramat
increas
caspas
inhibit
thu
cleavag
would
prevent
proper
express
downstream
target
subsequ
full
reactiv
kshv
suggest
allow
kshv
maintain
persist
infect
describ
amdv
protein
cleav
caspas
allow
full
viral
replic
interestingli
amdv
capsid
protein
also
process
caspas
viral
infect
ectop
cleavag
gener
stabl
product
vpx
partli
prevent
pharmacolog
inhibit
caspas
complet
pan
caspas
inhibitor
besid
vp
protein
express
either
transfect
amdvinfect
cell
mainli
activ
caspas
follow
caspas
caspas
effici
vp
cleavag
vitro
altogeth
data
argu
involv
sever
caspas
vp
cleavag
amdvg
strain
grow
effici
alter
caspas
site
within
amdvg
increas
vp
genom
copi
product
nonoptim
temperatur
show
signific
effect
suggest
vp
caspas
cleavag
attenu
amdvg
life
cycl
vivo
amdvg
infect
might
thu
regul
activ
caspas
occur
interestingli
cleavag
favor
viral
dna
replic
vp
process
would
limit
packag
progeni
virion
possibl
vp
cleavag
inevit
occur
simultan
depend
pattern
activ
caspas
would
result
either
effect
attenu
viral
replic
allow
viru
spread
persist
parvoviru
display
oncotrop
oncolyt
featur
mean
preferenti
replic
kill
transform
cell
mainli
nonapoptot
manner
howev
abl
activ
caspas
nontransform
cell
lead
cleavag
nonstructur
protein
ns
notabl
involv
viral
dna
replic
gene
express
transactiv
promot
control
synthesi
capsid
protein
cleav
protein
name
lack
ctermin
transactiv
domain
ectop
express
act
domin
neg
promot
transactiv
dramat
decreas
viral
product
moreov
molecular
clone
express
uncleav
version
tend
gener
virion
cancer
cell
often
refractori
proper
apoptot
induct
propos
oncotrop
due
least
part
inabl
cancer
cell
cleav
protein
thu
allow
strong
viru
product
hand
cleavag
would
act
sensor
antivir
defens
accordingli
attenu
viral
amplif
like
favor
persist
infect
unpublish
result
crimeancongo
hemorrhag
fever
viru
cchfv
caus
sever
coagul
dysfunct
human
cchfv
nucleocapsid
protein
np
import
structur
protein
also
involv
viral
replic
ectop
express
apoptot
factor
bax
protein
gener
two
fragment
cleavag
consensu
caspas
inhibitor
cell
lack
caspas
allow
one
logincreas
product
virion
suggest
caspas
activ
involv
cchfv
attenu
thu
np
caspas
cleavag
andor
nprelat
product
may
particip
attenu
although
mechan
remain
investig
interestingli
caspas
cleavag
site
conserv
within
strain
check
suggest
import
featur
cchfv
regul
caspas
cleavag
viral
protein
result
attenu
viru
rather
weak
viru
might
consid
way
viru
adapt
cellular
context
result
viral
attenu
host
respons
larg
reduc
viru
keep
abil
replic
extent
clear
evid
concern
relev
viral
protein
caspas
cleavag
physiolog
virus
figur
coher
modif
use
directli
fight
apoptosi
acmnpv
well
wssv
express
protein
act
strong
broad
inhibitor
caspas
substrat
virus
caspas
cleavag
probabl
allow
remov
specif
region
reveal
elimin
function
domain
signal
case
lead
full
viral
amplif
amdv
hpv
strike
exampl
amdv
protein
need
cleav
caspas
transloc
nucleu
eventu
exert
function
contrari
caspas
cleavag
result
attenu
viru
gener
new
viral
product
act
domin
neg
ns
protein
kshv
unfit
viru
packag
structur
protein
concern
amdv
vp
possibl
fcv
capsid
protein
interestingli
attenu
cellular
level
might
hold
import
regard
possibl
virus
establish
permiss
andor
persist
infect
higher
scale
ie
multicellular
organ
function
consequ
viral
protein
caspas
cleavag
still
remain
debat
elus
difficulti
investig
hazard
entiti
influenza
hcv
multitud
strain
genotyp
influenza
hcv
adenoviru
lack
appropri
tool
cellular
anim
model
allow
recapitul
viral
life
cycl
tgev
mcv
caspas
cleavag
viral
protein
work
mysteri
way
sometim
conclud
constitut
mechan
degrad
result
host
fight
back
infect
howev
caspaserel
product
detect
mostli
stabl
suggest
could
somehow
involv
viral
life
cycl
mention
right
besid
know
high
mutat
rate
virus
viral
oncoprotein
like
vrel
adapt
resist
caspas
cleavag
evolut
unlik
cellular
keep
caspas
cleavag
site
seem
unlik
virus
somehow
profit
caspas
cleavag
viral
protein
occur
sort
protein
structur
nonstructur
sort
virus
dna
well
rna
suggest
constitut
strong
strategi
handl
apoptosi
manag
use
molecular
effector
apoptosi
protect
erad
without
addit
genet
inform
requir
virus
prove
fascin
adapt
